The company expects 2025 adjusted earnings per share of $6.30 to $6.40, up from a prior forecast of $6.00 to $6.20, it said in a statement Thursday. CVS raised its guidance after its Aetna health insurance arm and its pharmacy unit outperformed expectations in the second quarter.
CVS shares rose 5.6% when markets opened in New York, after gaining 39% since the start of the ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.